GlassScriptPhysician profile
Dina Abukharma
NPI 1083483580
$1,830.28
in general payments reported to CMS, 2019-2025
29 companies · $755 in 2025
The $755 reported for 2025 was more than what 80% of Adult Health (Nurse Practitioner) providers received nationally (typical 2025 total: $182).
See the full distribution for Adult Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $1,075 · 2025: $755.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,830.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,830.28 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| United Therapeutics Corporation | $179.36 | 2024 | Remodulin, Orenitram |
| Impulse Dynamics (USA) INC. | $166.67 | 2024 | Optimizer |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $136.78 | 2024-2025 | Lifevest |
| Corcept Therapeutics | $136.41 | 2025 | Korlym |
| Merck Sharp & Dohme LLC | $105.35 | 2024-2025 | Winrevair, Verquvo |
| Novo Nordisk INC | $102.85 | 2025 | |
| Actelion Pharmaceuticals US, INC. | $96.18 | 2024 | Uptravi, Opsumit |
| Baxter Healthcare | $88.12 | 2025 | Hillrom - Cardiac Ambulatory Monitor, Hillrom - Carnation Ambulatory Monitor |
| Daiichi Sankyo INC. | $84.00 | 2024-2025 | Injectafer |
| Daxor Corporation | $82.55 | 2024 | Bva-100 |
| Lexicon Pharmaceuticals, INC. | $67.78 | 2024 | Inpefa |
| Boehringer Ingelheim Pharmaceuticals, INC. | $61.09 | 2024-2025 | Jardiance |
| Astrazeneca Pharmaceuticals LP | $59.72 | 2024-2025 | Farxiga |
| Endotronix, INC. | $57.25 | 2024-2025 | Cordella Pulomonary Artery Pressure Sensor |
| Novartis Pharmaceuticals Corporation | $46.45 | 2024 |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cvrx, INC. | $43.54 | 2024 | Barostim Neo System |
| Amgen INC. | $34.77 | 2024-2025 | Repatha |
| Alnylam Pharmaceuticals INC. | $34.36 | 2025 | Onpattro |
| Abiomed | $31.99 | 2024 | Impella |
| Bayer Healthcare Pharmaceuticals INC. | $28.95 | 2024-2025 | |
| Stryker Corporation | $28.45 | 2024-2025 | Sage Air Tap Lc |
| Heartflow, INC. | $24.70 | 2025 | |
| Boston Scientific Corporation | $24.49 | 2025 | Latitude Communicator Power Supply |
| Philips North America LLC | $24.09 | 2025 | Mcot |
| Kestra Medical Technology Services, INC. | $18.95 | 2025 | Assure Wcd |
| Cleerly, INC. | $18.84 | 2025 | Cleerly Ischemia, Cleerly Labs |
| Pfizer INC. | $16.44 | 2025 | |
| Kiniksa Pharmaceuticals International, Plc | $16.14 | 2024 | Arcalyst |
| Nuwellis, INC. | $14.01 | 2024 | Aquadex Smartflow Console |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dina Abukharma listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.